Skip to main content

Market Overview

Aclaris Therapeutics (NASDAQ: ACRS)

18.29 +0.13 (0.72%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
Pre-Market
EPS:
REV:
-0.57
1.777M



Q4 2021
Pre-Market
EPS:
REV:
-0.30
1.58M



Q3 2021
Pre-Market
EPS:
REV:
-0.25
1.449M



Q2 2021
Pre-Market
EPS:
REV:
-0.28
2.046M



Q1 2021
Pre-Market
EPS:
REV:
-0.37
1.407M
-0.29
1.69M
-0.57
1.777M
-96.55%
5.15%
Q4 2020
Pre-Market
EPS:
REV:
-0.45
1.095M

-0.30
1.58M

Q3 2020
Pre-Market
EPS:
REV:
-0.56
983K

-0.25
1.449M

Q2 2020
Pre-Market
EPS:
REV:
-0.76
5.865M

-0.28
2.046M

Q1 2020
After-Hours
EPS:
REV:
-0.91
1.263M

-0.37
1.407M

Q4 2019
After-Hours
EPS:
REV:
-0.99
3.669M
-1.24
3.47M
-0.45
1.095M
63.71%
-68.44%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!